Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zometa now available in Canada for hypercalcemia of malignancy

Dec. 12, 2000

Amylin seeks FDA approval for Symlin as adjuvant treatment in diabetes

Dec. 12, 2000

ARANESP effective given once weekly, and possibly less frequently, in treating anemia

Dec. 11, 2000

Testosterone buccal tablet enters late-stage clinical testing

Dec. 11, 2000

RUTH trial expanded to include invasive breast cancer prevention as main objective

Dec. 7, 2000

Genzyme General licenses small molecules with potential in lysosomal storage disease therapy

Dec. 7, 2000

Roche and deCODE Genetics identify chromosomal location of osteoporosis gene

Dec. 6, 2000

SB-251353-stimulated neutrophils show enhanced bactericidal activity

Dec. 6, 2000

Novel series of vitronectin receptor antagonists claimed by BASF

Dec. 6, 2000

NPY antagonists and their use in obesity described by Pfizer

Dec. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
SKL-35501 shows broad antitumor activity in solid tumors
BioWorld Science
Neurotensin receptor 1 (NTSR1) is overexpressed in several aggressive solid tumors, including colorectal and pancreatic cancer, making it a promising therapeutic...